Header cover image

Hong Kong (HSI) Healthcare Sector Analysis

UpdatedMay 17, 2022
DataAggregated Company Financials
Companies173
  • 7D2.5%
  • 3M-19.6%
  • 1Y-57.2%
  • YTD-32.5%

In the last week, the Healthcare industry is up 2.5%, with WuXi Biologics (Cayman) up 5.3%. In the same time, Shanghai MicroPort MedBot (Group) was down 13%. In the past year, the industry is down 57%. Earnings are forecast to grow by 27% annually.

Sector Valuation and Performance

Has the Hong Kong Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Wed, 18 May 2022HK$1.6tHK$1.3t-HK$2,895,966,144.0013.3x
Fri, 15 Apr 2022HK$1.7tHK$1.4t-HK$2,435,310,137.0013.6x
Sun, 13 Mar 2022HK$1.7tHK$1.3tHK$10.1b12.8x
Tue, 08 Feb 2022HK$2.0tHK$1.3tHK$7.9b14.4x
Thu, 06 Jan 2022HK$2.2tHK$1.3tHK$7.8b15.9x
Sat, 04 Dec 2021HK$2.5tHK$1.3tHK$8.0b14.9x
Mon, 01 Nov 2021HK$2.6tHK$1.3tHK$8.6b14.5x
Wed, 29 Sep 2021HK$2.8tHK$1.3tHK$8.0b15.2x
Fri, 27 Aug 2021HK$2.8tHK$1.3tHK$7.2b17.6x
Sat, 03 Jul 2021HK$3.9tHK$1.3tHK$7.4b18.9x
Tue, 06 Apr 2021HK$3.4tHK$1.2tHK$42.2m16.4x
Fri, 08 Jan 2021HK$2.7tHK$1.1tHK$9.1b18.5x
Thu, 01 Oct 2020HK$2.3tHK$1.1tHK$21.9b17.9x
Sun, 05 Jul 2020HK$2.3tHK$997.1bHK$21.1b20.6x
Wed, 08 Apr 2020HK$1.5tHK$1.0tHK$27.8b19x
Tue, 31 Dec 2019HK$1.5tHK$1.0tHK$31.8b17.8x
Fri, 04 Oct 2019HK$1.3tHK$970.9bHK$39.8b15.3x
Mon, 08 Jul 2019HK$1.3tHK$953.1bHK$38.8b15.9x
Median PE Ratio

15.2x


Total Market Cap: HK$1.1tTotal Earnings: HK$36.6bTotal Revenue: HK$913.8bTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Healthcare Sector Median PE3Y Average 17.1x202020212022
Current Industry PE
  • Investors are relatively neutral on the industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 17.2x.
Past Earnings Growth
  • Total earnings for the Healthcare industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 12% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Hong Kong Healthcare sector?

HK Market0.053%
Healthcare2.46%
Life Sciences5.37%
Pharma3.79%
Healthtech2.92%
Healthcare Services1.18%
Medical Equipment1.11%
Biotech-0.46%
Industry PE
  • Investors are most optimistic about the Healthtech industry even though it's trading below its 3-year average PE ratio of 10kx.
  • Analysts are expecting annual earnings growth of 43%, which is higher than its past year's earnings decline of 52% per year.
  • Investors are most pessimistic about the Pharma industry, which is trading below its 3-year average of 12.5x.
Forecasted Growth
  • Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 64% over the next 5 years.
  • This is better than its past earnings growth rate of 44% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 6.3% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
2269 WuXi Biologics (Cayman)HK$54.303.2%
+HK$7.2b
-50.6%PS58x
1093 CSPC Pharmaceutical GroupHK$7.945.0%
+HK$4.5b
-28.9%PS14.6x
2096 Simcere Pharmaceutical GroupHK$9.8419.0%
+HK$4.1b
20.0%PS14.9x
1177 Sino BiopharmaceuticalHK$4.055.5%
+HK$3.9b
-54.3%PS4.5x
1548 Genscript BiotechHK$20.858.4%
+HK$3.4b
-16.9%PS10.9x
Simply Wall St‚ĄĘ
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News